title: [Early therapy of osteoporosis with (1-38) parathyroid hormone and calcitonin nasal spray].
authors.forename: R D
authors.initials: RD
authors.lastname: Hesch
authors.forename: E F
authors.initials: EF
authors.lastname: Rittinghaus
authors.forename: H M
authors.initials: HM
authors.lastname: Harms
authors.forename: G
authors.initials: G
authors.lastname: Delling
mesh_terms: D000281:Administration, Intranasal; D015519:Bone Density / Q000187:drug effects; D002116:Calcitonin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000628:therapy*; D015663:Osteoporosis, Postmenopausal / Q000628:therapy; D010281:Parathyroid Hormone / Q000008:administration & dosage*; D010446:Peptide Fragments / Q000008:administration & dosage*
chemical_list: D010281:Parathyroid Hormone; D010446:Peptide Fragments; C035747:parathyroid hormone (1-38); D002116:Calcitonin
vernacular_title: Die Frühtherapie der Osteoporose mit (1-38) Parathormon und Calcitonin-Nasalspray.